Kempen Capital Management Has Upped Mrc Global Com (MRC) Holding; Allscripts Healthcare Solutions Has 1.45 Sentiment

December 7, 2017 - By Adrian Mccoy

Allscripts Healthcare Solutions, Inc. provides information technology and services to healthcare organizations in the United States, Canada, and internationally. The company has market cap of $2.53 billion. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. It currently has negative earnings. The companyÂ’s Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services.

Kempen Capital Management increased Mrc Global Inc Com (MRC) stake by 133.44% reported in 2017Q2 SEC filing. Kempen Capital Management acquired 70,819 shares as Mrc Global Inc Com (MRC)’s stock declined 1.90%. The Kempen Capital Management holds 123,890 shares with $2.05M value, up from 53,071 last quarter. Mrc Global Inc Com now has $1.51B valuation. The stock increased 0.70% or $0.11 during the last trading session, reaching $15.92. About 56,249 shares traded. MRC Global Inc. (NYSE:MRC) has risen 52.93% since December 7, 2016 and is uptrending. It has outperformed by 36.23% the S&P500.

Among 13 analysts covering MRC Global (NYSE:MRC), 7 have Buy rating, 0 Sell and 6 Hold. Therefore 54% are positive. MRC Global had 29 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of MRC Global Inc. (NYSE:MRC) earned “Outperform” rating by Cowen & Co on Monday, August 7. The rating was maintained by Robert W. Baird on Friday, September 8 with “Hold”. The stock of MRC Global Inc. (NYSE:MRC) earned “Outperform” rating by Cowen & Co on Tuesday, November 8. On Thursday, February 25 the stock rating was downgraded by Longbow to “Neutral”. The rating was downgraded by Maxim Group on Tuesday, November 10 to “Hold”. On Monday, November 9 the stock rating was downgraded by KeyBanc Capital Markets to “Sector Perform”. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, July 6. As per Tuesday, April 11, the company rating was initiated by Susquehanna. The rating was maintained by Maxim Group with “Buy” on Thursday, August 6. Seaport Global Securities upgraded the shares of MRC in report on Tuesday, February 21 to “Buy” rating.

Investors sentiment increased to 1.04 in Q2 2017. Its up 0.11, from 0.93 in 2017Q1. It is positive, as 20 investors sold MRC shares while 58 reduced holdings. 27 funds opened positions while 54 raised stakes. 91.26 million shares or 2.63% more from 88.92 million shares in 2017Q1 were reported. American Century invested in 0.01% or 339,751 shares. Fmr Limited Co reported 0.01% stake. Point72 Asia (Hong Kong) Limited reported 0% in MRC Global Inc. (NYSE:MRC). Bokf Na stated it has 759,045 shares or 0.39% of all its holdings. Wells Fargo Mn accumulated 2.09 million shares. 9,854 are held by Great West Life Assurance Can. D E Shaw And Co holds 0.06% of its portfolio in MRC Global Inc. (NYSE:MRC) for 2.34M shares. Rhumbline Advisers stated it has 0% of its portfolio in MRC Global Inc. (NYSE:MRC). Brown Brothers Harriman &, New York-based fund reported 1,000 shares. Redwood Investments Limited Liability Co has invested 0.02% in MRC Global Inc. (NYSE:MRC). Los Angeles Cap And Equity Rech has 31,340 shares. Buckhead Mgmt Ltd Liability Company owns 48,125 shares. Synovus Financial holds 0.01% of its portfolio in MRC Global Inc. (NYSE:MRC) for 24,815 shares. Frontier Cap Mgmt Com Ltd Liability Corporation reported 0.31% of its portfolio in MRC Global Inc. (NYSE:MRC). Mackenzie has 1.17M shares.

Kempen Capital Management decreased Abbvie Inc Com (NYSE:ABBV) stake by 34,800 shares to 329,900 valued at $23.92 million in 2017Q2. It also reduced Select Comfort Corp Com (NASDAQ:SCSS) stake by 16,299 shares and now owns 95,041 shares. Camden Ppty Tr Sh Ben Int (NYSE:CPT) was reduced too.

Ratings analysis reveals 29% of Allscripts-Misys Healthcare’s analysts are positive. Out of 7 Wall Street analysts rating Allscripts-Misys Healthcare, 2 give it “Buy”, 1 “Sell” rating, while 4 recommend “Hold”. The lowest target is $14.0 while the high is $17.0. The stock’s average target of $15.60 is 11.59% above today’s ($13.98) share price. MDRX was included in 7 notes of analysts from August 5, 2015. RBC Capital Markets maintained Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) on Wednesday, August 5 with “Sector Perform” rating. The stock of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has “Buy” rating given on Tuesday, January 10 by Maxim Group. The stock of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has “Neutral” rating given on Friday, December 2 by Dougherty & Company. The rating was upgraded by Leerink Swann on Tuesday, August 23 to “Outperform”. On Tuesday, December 13 the stock rating was downgraded by Morgan Stanley to “Underweight”. Topeka Capital Markets maintained the shares of MDRX in report on Wednesday, August 5 with “Hold” rating. The rating was upgraded by Argus Research to “Hold” on Monday, August 24.

Blue Harbour Group L.P. holds 4.58% of its portfolio in Allscripts Healthcare Solutions, Inc. for 9.31 million shares. Glenhill Advisors Llc owns 5.51 million shares or 4.43% of their US portfolio. Moreover, Adirondack Research & Management Inc. has 2.85% invested in the company for 574,033 shares. The New York-based Paradigm Capital Management Inc Ny has invested 2.25% in the stock. S&T Bank Pa, a Pennsylvania-based fund reported 705,807 shares.

The stock decreased 0.07% or $0.01 during the last trading session, reaching $13.98. About 28,793 shares traded. Allscripts Healthcare Solutions, Inc. (MDRX) has declined 8.32% since December 7, 2016 and is downtrending. It has underperformed by 25.02% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com